Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

84.61 +1.23 (+1.48%)
Streaming Delayed Price Updated: 11:59 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales ↗
 
Via Benzinga
News headline image
Recap: Edwards Lifesciences Q1 Earnings ↗
Edwards Lifesciences (NYSE:EW) reported its Q1 earnings results on Tuesday, April 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Medtech Giant Edwards Lifesciences Tumbles Despite First-Quarter Beat ↗
The medtech giant narrowly beat first-quarter sales and earnings views. 
Via Investor's Business Daily
News headline image
Earnings Scheduled For April 26, 2022 ↗
Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.09 per share on revenue of $46.41 million. 
Via Benzinga
News headline image
Market Briefing For Monday, April 25 ↗
It's clearly on the edge of the generals completing their retreat to join troops already in the trenches. Nevertheless the same variables prevail; it's hard to project any sustainable rallies. 
Via Talk Markets
News headline image
Establishment Labs Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating ↗
Establishment Labs stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 92, up from 87 the day before. 
Via Investor's Business Daily
News headline image
Expert Ratings for Edwards Lifesciences ↗
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: 
Via Benzinga
News headline image
Where Edwards Lifesciences Stands With Analysts ↗
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: 
Via Benzinga
News headline image
Edwards Lifesciences Dips On Narrow Quarterly Miss, Light Outlook ↗
Edwards issued light 2022 guidance after a fourth-quarter disappointment. 
Via Investor's Business Daily
News headline image
Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade ↗
Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91. 
Via Investor's Business Daily
News headline image
Five Of The Best Chinese Stocks To Keep An Eye On
This year has been a stellar one for the Chinese stock market. After a year that saw the Shanghai Stock 
Via Best Stocks
News headline image
Pfizer Stock, Raytheon Lead 5 Stocks Near Buy Points ↗
Pfizer, Raytheon lead stocks shielded from geopolitics and rate hikes. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Raytheon, Shell Lead Five Stocks Setting Up, Breaking Out From Strong Sectors ↗
Raytheon and Shell are just below buy points. They have good company. 
Via Investor's Business Daily
News headline image
7 Medical Device Stocks to Buy as Covid-19 Fears Fade ↗
With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks. 
Via InvestorPlace
News headline image
3 Top S&P 500 Stock Market Gainers Today: Medicals Lead As This Sector Reverses Hard ↗
Medical and gold stocks led the S&P 500. Transport stocks were big losers. 
Via Investor's Business Daily
News headline image
FDA Approves Edwards Lifesciences' Resilia Valve For Mitral Replacement Surgery ↗
The FDA has approved Edwards Lifesciences Corp's (NYSE: EW) Mitris Resilia valve, a tissue valve replacement specifically designed for the heart's mitral... 
Via Benzinga
News headline image
What 9 Analyst Ratings Have To Say About Edwards Lifesciences ↗
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... 
Via Benzinga
News headline image
Analyst Ratings For Edwards Lifesciences ↗
Analysts have provided the following ratings for Edwards Lifesciences (NYSE:EW) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022 ↗
Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to... 
Via Benzinga
News headline image
This Foreboding Sign Looms Over Edwards Lifesciences's Chart ↗
If history is any guide, there may be trouble ahead for shares of Edwards Lifesciences (NYSE:EW). A so-called "death cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022 ↗
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
News headline image
Stock Market Whipsaws Lower On Hawkish Fed, Tesla; Apple, Microsoft Earnings Strong: Weekly Review ↗
Microsoft and Apple earnings were strong, but the correction is getting worse. 
Via Investor's Business Daily
News headline image
Edwards Lifesciences Q4 Earnings Fall Short Of Expectations, Reaffirms FY22 Outlook ↗
Heart device company Edwards Lifesciences Corp (NYSE: EW) posted Q4 adjusted EPS of $0.51, compared to $0.50 posted a year ago and below the consensus of $0.55.... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Reneo Pharmaceuticals (NASDAQ:RPHM 
Via Benzinga
News headline image
Edwards Lifesciences: Q4 Earnings Insights ↗
Edwards Lifesciences (NYSE:EW) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
5 Big Cap Earnings All Stars to Watch This Week ↗
Some of these companies have perfect 5-year earnings surprise track records, even beating through the early months of the pandemic. It’s impressive. 
Via Talk Markets
News headline image
Earnings Scheduled For January 26, 2022 ↗
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to... 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.